P-1	Refractoriness to cancer cell reprogramming unveils cancer type-specific therapeutic targets
	Kohei Nagata （Division of Stem Cell Pathology, Institute of Medical Science, University of Tokyo）

P-2	DMRT1-mediated in vivo reprogramming drives development of cancer resembling human germ cell tumors with totipotency features
	Jumpei Taguchi （Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology,Institute of Medical Science, University of Tokyo）

P-3	JARID1 family inhibitor prevents EGFR tyrosine kinase inhibitor　resistant lung cancer cell expansion
	Shin Ariga （Department of Medical Oncology Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan）

P-4	The epigenetic role of nucleoporin RAE1 in human breast cancer
	Dini Kurnia Ikliptikawati （Kanazawa University）

P-5	IDH1/2 mutation induces mis-splicing in gliomas
	Michiko Kurikawa （Cancer RNA Research Unit, National Cancer Center Research Institute）

P-6	Max regulates meiotic entry in mouse germ cells
	Ayumu Suzuki （Division of Developmental Biology, Research Center for Genomic Medicine, Saitama Medical University）

P-7	Identification and functional analysis of a novel head and neck squamous cell carcinoma-associated long non-coding RNA
	Takeshi Niinuma （Sapporo Medical University of Medicine, Department of Molecular Biology）

P-8	Long non-coding RNA lncAC1 promotes colorectal cancer progression
	Masayo Koizumi （Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University）

P-9	DLEU1 regulates expression and histone modification of interferon-related genes and promotes oral squamous cell carcinoma progression.
	Yui Hatanaka （Department of Oral Surgery, Sapporo Medical　University School of Medicine）

P-10	Autoimmune gastritis induced aberrant DNA methylation reflecting its carcinogenic potential
	Chihiro Takeuchi （Division of Epigenomics, National Cancer Center Research Institute）

P-11	Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level
	Hideyuki Takeshima （Division of Epigenomics, National Cancer Center Research Institute）

P-12	A long non-coding RNA associated with chronic gastritis and gastric cancer promotes stress granule formation and inhibits apoptosis
	Hiroshi Kitajima （Department of Basic Medical Science Dept.of Molecullar Biology, Sapporo Medical University）

P-13	Identification of long non-coding RNA and protein interactions through CRISPR-Cas13 system
	Jingqi Xie （Department of Cancer Biology, Nagoya University Graduate School of Medicine, Japan）

P-14	Analysis of AEBP1 in the microenvironment of head and neck squamous cell carcinoma
	Shohei Sekiguchi （Department of Oral Surgery, Sapporo Medical University School of Medicine.）

P-15	Upregulation of adipocyte enhancer-binding protein 1 in endothelial cells promotes tumor angiogenesis in colorectal cancer
	Akira Yorozu （Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan）

P-16	Analysis of the expression of Tagln in Cancer-associated fibroblasts of pancreatic ductal adenocarcinoma (PDAC)
	Wang Xingxing （Nagoya University）

P-17	Functional analysis of Diacylglycerol kinase gamma in melanoma
	Masahiro Kai （Dept. of Molecular Biology, Sapporo Medical University, School of Medicine.）

P-18	Tumor endothelial cells induce metastasis by neutrophil recruitment into tumor via LOX-1/Oxidized LDL axis
	Takuya Tsumita （Vascular Biology and Molecular Pathology, Graduate School of Dental Medicine, Hokkaido University）

P-19	Aberrant high expression of ALDOA contributes to the malignant transformation of uterine cervical adenocarcinoma.
	Akira Takasawa （Deptartment of Pathology, Sapporo Medical University.）

P-20	Trib1 promotes the development of acute myeloid leukemia in the Ts1Cje Down syndrome model mouse
	Seiko Yoshino （Division of Molecular Oncology, Nagoya University, Graduate School of Medicine）

P-22	RUNX1-ETO induces myeloid leukemia in mice in an age-dependent manner.
	Motomi Osato （Cancer Science Institute, National University of Singapore）

P-23	BCL11A promotes myeloid leukemogenesis by abrogating transcriptional activity of PU.1
	Yoshitaka Sunami （Division of Carcinogenesis, The Cancer Institute of JFCR）

P-24	Molecular mimicry of niche-interacting status by ITGA9 overexpression underlies the extramedullary maintenance of leukemia stem cells in AML
	Akiko Nambu （Cancer Science Institute of Singapore, National University of Singapore）

P-25	Mutations in the RNA Splicing Factor SF3B1 Target PPP2R5A to Promote Tumorigenesis through MYC Stabilization
	Hirofumi Yamauchi （Cancer RNA Research Unit, National Cancer Center Research Institute, Japan.）

P-21	CD24, an immunosuppressive immune checkpoint, is up-regulated in EGFR-mutated non-small lung cancer cell lines upon EGFR-TKI treatment.
	Takuro Noguchi （Department of Medical Oncology, Hokkaido University Graduate School of Medicine）

P-26	Identification of Amomum xanthioides as a natural medicine to enhance anti-tumor effecter function of natural killer cells
	Yoshimasa Yamamoto （Laboratory of Cancer Biology and Immunology, Section of Host Defences, Division of Bioscience, Department of Research and Development, Institute of Natural Medicine, University of Toyama）

P-27	Analysis of cancer stem cell-specific cancer antigens in bladder cancer cell lines
	Shuhei Yamada （Department of Pathology, Sapporo Medical University）

P-28	Angiogenic inhibitor administration prior to immunotherapy improves the therapeutic effects
	Mineyoshi Sato （Vascular Biology and Molecular Pathology, Graduate School of Dental Medicine, Hokkaido University）

P-29	Identification of HLA class II-presenting neoantigens in colon cancer by proteogenomics HLA ligandome analysis
	Satoru Matsumoto （Department of Pathology, Sapporo Medical University School of Medicine）

P-30	A novel HLA class I peptide encoded by a long non-coding RNA, PVT1
	Yasuhiro Kikuchi （Department of Pathology, Sapporo Medical University School of Medicine, Japan）

P-31	Identification of primate-specific gene as a novel prognosticator gene in malignant pancreatic cancer
	Shoichiro Tange （Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University）

P-32	Generation of a reporter mouse line to visualize p16 protein expression in vivo.
	Yui Shimada （The Institute of Medical Science, The University of Tokyo）

P-33	Determining the sites of DNA damage inducing cellular senescence by a CRISPR screen
	Satoshi T Ito （Graduate School of Frontier Science, the University of Tokyo）

P-34	Roles of claudin-1 in cell adhesion and microvilli formation of cervical adenocarcinoma cells
	Kumi Takasawa （Dept. of Pathology, Sapporo Medical University School of Medicine）

P-35	Effect of scaffold stiffness on hydrogel-induced cancer stemness of cancer model cells
	Yanpeng Sun （Department of Cancer Pathology, Faculty of Medicine, Hokkaido University）

P-36	Analysis of epigenetic characteristics of sarcoma stem cells induced by multifunctional hydrogels
	Yuheng Nie （Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan）

P-37	GSk3iIX suppress the proliferation and GLUT3 expression through decreased β-catenin in CACO-2 cells
	Tomoko Sakyo （Iwate Medical University School of Pharmacy Department of Clinical Pharmacy Division of Integrated information for Pharmaceutical Sciences）